Parabacteroides distasonis-Derived Outer Membrane Vesicles Enhance Antitumor Immunity Against Colon Tumors by Modulating CXCL10 and CD8+ T Cells
Rongyao Liang,Pei Li,Na Yang,Xiaoyi Xiao,Jing Gong,Xingyuan Zhang,Yunuan Bai,Yanlong Chen,Zhiyong Xie,Qiongfeng Liao
DOI: https://doi.org/10.2147/dddt.s457338
IF: 4.3188
2024-05-29
Drug Design Development and Therapy
Abstract:Rongyao Liang, 1, &ast Pei Li, 1, 2, &ast Na Yang, 1 Xiaoyi Xiao, 1 Jing Gong, 1 Xingyuan Zhang, 1 Yunuan Bai, 1 Yanlong Chen, 1 Zhiyong Xie, 3 Qiongfeng Liao 1 1 School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, People's Republic of China; 2 Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, People's Republic of China; 3 School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qiongfeng Liao, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, People's Republic of China, Tel +86 2039358081, Email Zhiyong Xie, School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou, 510006, People's Republic of China, Tel +86 075523260207, Email Purpose: Given the potent immunostimulatory effects of bacterial outer membrane vesicles (OMVs) and the significant anti-colon tumor properties of Parabacteroides distasonis ( Pd ), this study aimed to elucidate the role and potential mechanisms of Pd -derived OMVs ( Pd -OMVs) against colon cancer. Methods: This study isolated and purified Pd -OMVs from Pd cultures and assessed their characteristics. The effects of Pd -OMVs on CT26 cell uptake, proliferation, and invasion were investigated in vitro. In vivo, a CT26 colon tumor model was used to investigate the anti-colon tumor effects and underlying mechanisms of Pd -OMVs. Finally, we evaluated the biosafety of Pd -OMVs. Results: Purified Pd -OMVs had a uniform cup-shaped structure with an average size of 165.5 nm and a zeta potential of approximately − 9.56 mV, and their proteins were associated with pathways related to immunity and apoptosis. In vitro experiments demonstrated that CT26 cells internalized the Pd -OMVs, resulting in a significant decrease in their proliferation and invasion abilities. Further in vivo studies confirmed the accumulation of Pd -OMVs in tumor tissues, which significantly inhibited the growth of colon tumors. Mechanistically, Pd -OMVs increased the expression of CXCL10, promoting infiltration of CD8 + T cells into tumor tissues and expression of pro-inflammatory factors TNF-α, IL-1β, and IL-6. Notably, Pd -OMVs demonstrated a high level of biosafety. Conclusion: This paper elucidates that Pd -OMVs can exert significant anti-colon tumor effects by upregulating the expression of the chemokine CXCL10, thereby increasing the infiltration of CD8 + T cells into tumors and enhancing antitumor immune responses. This suggests that Pd -OMVs may be developed as a novel nanoscale potent immunostimulant with great potential for application in tumor immunotherapy. As well as developed as a novel nano-delivery carrier for combination with other antitumor drugs. Keywords: Parabacteroides distasonis , outer membrane vesicles, colon tumor, CXCL10, CD8 + T cells Graphical Colon cancer ranks as the third leading cause of cancer-related deaths, being one of the most prevalent gastrointestinal malignancies. There is growing evidence that the incidence of colon cancer is rapidly increasing among young individuals. 1,2 The increased risk of colon cancer is strongly linked to unhealthy lifestyle factors like smoking, high sugar diets, excessive alcohol consumption and inadequate physical activity. 3 The treatment modalities for colon cancer include surgery, radiation therapy, chemotherapy, and immunotherapy. Depending on the location of the cancer, number of metastases and tumor progression, colon cancer patients may receive an individualized treatment strategy. For chemotherapy, approved drugs are commonly used, including bevacizumab, irinotecan hydrochloride and capecitabine. 4 However, these drugs tend to cause serious adverse effects in the digestive tract and nervous system during clinical treatment. Additionally, drug resistance and organ toxicity of chemotherapeutic drugs are also the key problems faced by chemotherapy. 5 In recent years, tumor immunotherapy has emerged as a promising frontier therapy in the field of fighting cancer, providing a new strategy to utilize the immune system for tumor eradication. Although immunotherapy has shown impressive efficacy and fewer adverse effects in some patients, studies hav -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal